Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, potentially transforming the global fight against the virus.

March 9, 2009 — An updated list of 93 surveillance drug resistance HIV-1 mutations is vital to tracking the AIDS epidemic, according to the results of a study reported in the March issue of PloS ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for ...

Gilead stock toppled Thursday after CVS HealthCVS said it won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now. The decision is based on clinical, financial and ...

The largest insurer in North Carolina recently lowered the out-of-pocket cost of its HIV drugs, including PrEP, after complaints from advocacy organizations to the state and federal governments. The ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more effectively and a much lower cost than many existing treatments, an initial clinical ...